Strategies for safe donor expansion: Donor management, donations after cardiac death, ex-vivo lung perfusion

Current Opinion in Organ Transplantation

Volumn 18, Issue 5, 2013, Pages 513-517

  Cypel, Marcelo ^a   Keshavjee, Shaf ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Donation after cardiac death; Donor management; Ex vivo perfusion

Indexed keywords

BODY TEMPERATURE; CLINICAL ASSESSMENT; EX VIVO LUNG PERFUSION; EX VIVO STUDY; HEART DEATH; HIGH RISK POPULATION; HUMAN; LONG TERM SURVIVAL; LUNG FUNCTION; LUNG PERFUSION; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; OUTCOME ASSESSMENT; PRIMARY GRAFT DYSFUNCTION; REVIEW; SAFETY; ADVERSE EFFECTS; ANIMAL; DEATH; DONOR; LUNG; PATHOPHYSIOLOGY; PERFUSION; PROCEDURES; SUPPLY AND DISTRIBUTION; SURGERY;

ANIMALS; DEATH; HUMANS; LUNG; LUNG TRANSPLANTATION; PERFUSION; PRIMARY GRAFT DYSFUNCTION; TISSUE DONORS;

EID: 84888292186     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328365191b     Document Type: Review

References (37)

1. Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 2008; 17 (Suppl 4):S41-S47.
2. Barnieh L, Baxter D, Boiteau P, et al. Benchmarking performance in organ donation programs: dependence on demographics and mortality rates. Can J Anaesth 2006; 53:727-731.
3. Daemen JW, Kootstra G, Wijnen RM, et al. Nonheart-beating donors: the Maastricht experience. Clin Transpl 1994; 303-316.
4. Hammainen P. Re: use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 2008; 27:1186.
5. Love RB, Stringham JC, Chomiak PN, et al. Successful lung transplantation using a nonheart-beating donor [abstract]. J Heart Lung Transplant 1995; 14:s88.
6. Klein AS, Messersmith EE, Ratner LE, et al. Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010; 10:973-986.
7. De Oliveira NC, Osaki S, Maloney JD, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010; 139:1306-1315.
8. De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, et al. Early outcome after lung transplantation from nonheart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant 2009; 28:380-387.
9. Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant 2009; 28:753-758.
10. Puri V, Scavuzzo M, Guthrie T, et al. Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg 2009; 88:1609-1614; discussion 14-15.
11. Mason DP, Murthy SC, Gonzalez-Stawinski GV, et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008; 27:561-563.
12. Mason DP, Thuita L, Alster JM, et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008; 136:1061-1066.
13. Snell GI, Levvey BJ, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008; 8:1282-1289.
14. Erasmus ME, Verschuuren EA, Nijkamp DM, et al. Lung transplantation from nonheparinized category III nonheart-beating donors: a single-centre report. Transplantation 2010; 89:452-457.
15. Tomasoni S, Azzollini N, Casiraghi F, et al. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000; 11:747-752.
16. Levvey BJ, Harkess M, Hopkins P, et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant 2012; 12:2406-2413.
17. Kang CH, Anraku M, Cypel M, et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2011; 30:289-298.
18. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a nonheartbeating donor. Lancet 2001; 357:825-829.
19. Gamez P, Cordoba M, Ussetti P, et al. Lung transplantation from out-ofhospital nonheart-beating lung donors. one-year experience and results. J Heart Lung Transplant 2005; 24:1098-1102.
20. de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled nonheart-beating donors. J Heart Lung Transplant 2007; 26:529-534.
21. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24:1454-1459.
22. Carrel A, Lindbergh CA. The culture of whole organs. Science 1935; 81:621-623.
23. Jirsch DW, Fisk RL, Couves CM. Ex vivo evaluation of stored lungs. Ann Thorac Surg 1970; 10:163-168.
24. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from nonheartbeating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252; discussion 52.
25. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83:2191-2194.
26. Erasmus ME, Fernhout MH, Elstrodt JM, Rakhorst G. Normothermic ex vivo lung perfusion of nonheart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006; 19:589-593.
27. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27:1319-1325.
28. D'Armini AM, Roberts CS, Griffith PK, et al. When does the lung die? I. Histochemical evidence of pulmonary viability after 'death'. J Heart Lung Transplant 1994; 13:741-747.
29. Alessandrini F, D'Armini AM, Roberts CS, et al. When does the lung die? II. Ultrastructural evidence of pulmonary viability after 'death'. J Heart Lung Transplant 1994; 13:748-757.
30. Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9:2262-2269.
31. Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1:4ra9.
32. Yeung JC, Cypel M, Machuca T, et al. Ex vivo evaluation of brain dead donor lungs: PO2 is not enough. J Heart Lung Transplant 2012; 31:S218-S219.
33. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364:1431-1440.
34. Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012; 144:1200-1206.
35. Wallinder A, Ricksten SE, Hansson C, et al. Ex-vivo perfusion and transplantation of initially rejected donor lungs. J Heart Lung Transplant 2012; 31:S98.
36. Warnecke G, Haverich A, Massard G, et al. The INSPIRE International Lung Trial with the Organ Care System Technology (OCS). J Heart Lung Transplant 2012; 31:S115.
37. Souilamas R, Souilamas JI Jr, Saueressig M, Briot R. Advanced normothermic ex vivo lung maintenance using the mobile Organ Care System. J Heart Lung Transplant 2011; 30:847-848.